Transcript Refractive surgery for Children
Magraby Eye and Ear Centre - OMAN
Difficulties with children and LA Reports of NO2 interference with Laser function Aim – compare propfol/fentanyl and ketamine/midazolam
Prospective 30 patients Randomized to 2 groups Age 3 to 12 years Aniso/Amblyopia
NBM overnight Clear fluids till 4 hours before LASIK or LASEK
Heart rate MABP SaO2 O2 by nasal cannula if SaO2 ≤ 90%
Matched for: age weight duration of anesthesia duration of surgery
Time to recovery shorter in P/F group Opposite effects on BP and HR P/F group 3 patients needed O2 Post-op agitation and vomiting higher in K/M group Airway obstruction (needing jaw thrust) higher in P/F group
Bells phenomenon Nystagmus Overall intra and post-op state No significant difference (used suction ring for fixation)
Propofol preferred Shorter acting Lower incidence of dysphoric effects Greater potential for airway compromise.
University of L’Aquila, Italy
Prospective 18 consecutive patients Mean age 32.4 (range 21 to 52) Accommodative eso (normal AC/A) No suppression 8 – PRK (Group A) 10 – LASIK (Group B)
ET’ 14.4
Without correction ∆ (10 to 19) ET 11.6
∆ (8 to 14) ET’ 5 ET 2.4
∆ ∆ With correction (4 to 6) (2 to 4) Mean 71.2 sec/arc
2 ∆ 1.2
esophoria – near ∆ esophoria – distance Refraction +4.6 D (mean) (range +3.50 to +6.00) Mean BSCVA – 20/20
ET’ 1.2
∆ 1 Year esophoria ET – orthophoric ET’ 2 ∆ ET 0.4
∆ 2 Years esophoria
Without correction ET’ 13.4
∆ (8 to 21) ET 11.5
∆ (6 to 19) With correction ET’ 5.4
ET 2.8
∆ ∆ (2 to 8) (orthophoria to 6) Mean 81 sec/arc
2.5
∆ 1.1
∆ esophoria – near esophoria – distance Refraction +6.46 D (mean) (range +5.00 to +8.50) Mean BSCVA – 20/20
ET’ 1.7
∆ ET 0.2
∆ 1 Year esophoria esophoria 2 Years No change
Only 1 case of regression Recurrence of ET
Good binocular function Good acuity Careful selection of patients ? Timing of surgery
Possible application to older children and young adults?????
Review by L.Tychsen
Corneal surface ablation Phakic IOL Clear Lens Exchange
Anisometropia – spectacle non-compliant 2.0 D - hypermetropes 3.0 to 4.0 D - myopes Intolerance of specs or CL Neuro-behavioural disorders
Iso-ametropia Spectacle non-compliant Amblyopia approaching 50% Neuro-behavioural disorders Visual autism
Other special needs Craniofacial deformities High hyperopia and esotropia Poor spectacle compliance
Baseline Repeated examinations EUA Surface ablation +6.0 to -10.0 D ACD ≥ 3.2 mm Phakic IOL Remainder - Clear lens extraction
Volatile induction Intravenous anaesthetic EUA LASEK or PTK/PRK BCL and goggles Epithelial healing as in adults Better tolerated
Artisan iris enclaved Bilateral sequential – 1 month interval Absorbable sutures Limbal relaxing incisions Arm band restraints
Above 20.0 D ACD ≤ 3.2 mm Lensectomy Posterior capsulectomy Anterior vitrectomy Acrylic IOL AL ≥ 29 mm - Prophylactic laser
Improvement in UCVA Best with bilateral ametropia Modest with anisometropia
Ametropia avg 7.1 D UCVA 20/180 to 20/60 (mean) If glasses worn - BCVA 2-fold improvement
Ametropia – mean 15.0 D UCVA 20/3400 to 20/57 (mean) Similar results with CLE
90% within 1.5 D of emmetropia Variable improvement in UCVA and BCVA No reported loss of acuity 50% improvement in fusion and stereopsis
Low Several years follow up Small numbers
260 eyes - 1998 to 2008 Negligible rate of sight-threatening complications LASIK – flap complications LASEK – thicker residual stroma Regression - 1.0 D/year ? Over-correction for myopes
No regression Corneal endothelium? Low rate of loss ? Posterior chamber IOLs ? Glaucoma/ Cataract
Accomodation Multifocal IOLS?
RD risk – 3% long term
Substantial benefits for selected patients Need more information/scrutiny/disclosure